Cell Signaling and Cell Decisions

细胞信号传导和细胞决策

• 批准号: 10292339
• 负责人: TOBIAS MEYER
• 金额: $ 75.88万
• 依托单位: WEILL MEDICAL COLL OF CORNELL UNIV
• 依托单位国家: 美国
• 财政年份: 2018
• 资助国家: 美国
• 起止时间: 2018-05-01 至 2023-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10292339
• 关键词: Actins; Architecture; Biochemical Genetics; Biological Assay; Cell Cycle; Cell Polarity; Cell Proliferation; Cells; Chemotaxis; Complex; DNA; Degenerative Disorder; Development; Disease; Ensure; Event; Family; Feedback; Fluorescence Microscopy; Goals; Human; Immune; Lead; Logic; Maintenance; Malignant Neoplasms; Mammalian Cell; Methods; Mitogens; Modeling; Molecular; Monitor; Monomeric GTP-Binding Proteins; Output; Process; Proliferating; Reporter; Second Messenger Systems; Signal Transduction; Stress; Structure; Therapeutic; Tissues; Work; cell motility; genetic approach; migration; novel therapeutic intervention; polarized cell; prevent; rho; single cell analysis; system architecture; treatment strategy

PROJECT SUMMARY/ABSTRACT Human cells integrate external and internal signaling inputs to make regulatory decisions that change functional outputs. Two such decisions of cells – the decision to polarize and migrate and the decision to enter the proliferative state - are central to multicellular development and tissue maintenance. The regulatory feedbacks and the core switch mechanisms of how cells start to migrate or proliferate are not yet understood. Due to significant cell-to-cell variability and lack of synchronization, an understanding of the underlying regulatory motifs cannot be achieved by biochemical and genetic approaches alone. However, recently developed activity reporters and rapid perturbation strategies have made it possible to investigate complex spatial and temporal signaling feedback architectures and decision processes in living single cells, an approach that can reveal feedback mechanisms and circumvent the technical bulk assay issues. Our work seeks to understand the principles of cellular decision processes in human cells by employing these live-cell methods to monitor, perturb and automatically analyze the relevant signaling processes and ultimately derive quantitative models of how specific decisions are made. Our proposed work has Two Themes: In our first theme, we determine how cells initiate and establish cell polarity and how already polarized cells steer their front during directed migration and chemotaxis. We have developed automated fluorescence microscopy methods to monitor and perturb the critical Rho family small GTPases and relevant second messengers, and developed methods to quantify changes in different actin structures. These approaches will allow us to understand the core regulatory mechanisms for cell polarization and cell steering during migration. In our second theme, we seek to understand how cells decide to transition from a quiescent to a proliferative state by investigating molecular mechanisms of competition between stress and mitogens, by determining the molecular mechanism of the point-of-no return for cell cycle entry, and by exploring how sequential signaling events prevent the re-replication of the same DNA to ensure that DNA is only replicated once. We have developed a number of live cell cycle activity reporters, perturbation strategies and automated single-cell analysis methods that will help us understand and model the regulatory mechanisms controlling human cell cycle entry. Both our themes will lead to new concepts of the logics of human decision processes and will provide detailed molecular and mechanistic models explaining how cells integrate signaling inputs to start to migrate or enter the cell cycle. Finally, the universal dysregulation of cell proliferation and migration in cancer, and the frequent dysregulation of these processes in degenerative, immune and other diseases, argues that a molecular understanding of the complex regulatory architecture of cell migration and proliferation may lead to new therapeutic strategies for the treatment of a broad range of diseases.

项目摘要/摘要 人类细胞整合外部和内部信号输入，以做出改变的调节决定 功能输出。细胞的两个这样的决定-极化和迁移的决定以及进入的决定 增殖状态是多细胞发育和组织维持的中心。监管机构 细胞如何开始迁移或增殖的反馈和核心开关机制尚不清楚。 由于细胞间显著的可变性和缺乏同步性，对潜在的 仅靠生化和遗传方法是不能实现调控模式的。不过，最近， 发达的活动记者和快速扰动策略使调查复杂的 活的单细胞中的时空信号反馈结构和决策过程，以及 一种可以揭示反馈机制并绕过技术批量分析问题的方法。我们的工作 试图通过使用这些活细胞来理解人类细胞中细胞决策过程的原理 监控、干扰和自动分析相关信号流程的方法，并最终得出 具体决策如何做出的量化模型。 我们提议的工作有两个主题：在第一个主题中，我们确定细胞如何启动和建立 细胞的极性，以及已经极化的细胞如何在定向迁移和趋化过程中引导它们的前沿。我们 已经开发出自动荧光显微镜方法来监测和干扰关键的Rho家族 小的GTP酶和相关的第二信使，并开发了量化不同 肌动蛋白结构。这些方法将使我们能够理解细胞的核心调控机制 迁移过程中的极化和细胞转向。在我们的第二个主题中，我们试图了解细胞如何决定 通过研究竞争的分子机制从静止状态转变到增殖状态 在应激和有丝分裂原之间，通过确定细胞周期的NO点返回的分子机制 条目，并通过探索顺序信号事件如何防止相同DNA的重新复制来确保 这种DNA只复制一次。我们已经开发出了一些活的细胞周期活动报告器， 策略和自动化的单细胞分析方法，将帮助我们了解和建模监管 控制人类细胞周期进入的机制。 我们的这两个主题都将导致人类决策过程的逻辑的新概念，并将提供 解释细胞如何整合信号输入以开始迁移或迁移的详细分子和机制模型 进入细胞周期。最后，癌症中普遍存在的细胞增殖和迁移的失调，以及 退行性疾病、免疫性疾病和其他疾病中这些过程的频繁失调，认为 对细胞迁移和增殖的复杂调控架构的分子理解可能会导致 治疗多种疾病的新治疗策略。